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Halogenated aromatic hydrocarbons (HAHs)
are ubiquituous in the environment. The
most toxic and best-studied of these com-
pounds is 2,3,7,8-tetrachlorodibenzo-p-diox-
in (TCDD). Numerous studies on the toxic
effects of TCDD have been done, most of
them on rodents. TCDD is tumor promot-
ing, teratogenic, and embryotoxic (1). One
ofthe earliest and most sensitive markers of
TCDD toxicity in experimental animals is
impairment ofthe immune system, which is
evident at doses that do not lead to overt
signs of general toxicity. TCDD leads to
atrophy oflymphoid organs, such as the thy-
mus, spleen, and lymph nodes (2).
Moreover, TCDD was shown to suppress
cellular and humoral immune functions in
experimental animals (2). Using a variety of
in vivo exposure schemes or in vitro assays,
TCDD was found to impair cytotoxic T-
lymphocytes and natural killer cell functions,
or inhibit antibody production by B-cells, for
example (2). The capacity to respond to
mitogenic stimuli, such as phytohemagglu-
tinin (PHA) and lipopolysaccharide (LPS), is
also affected byTCDD (3,4).
Susceptibility to the toxicity of TCDD
is genetically determined by the aryl hydro-
carbon receptor (AhR) locus. This gene
codes for a cytosolic, TCDD-binding pro-
tein that is activated to a DNA-binding
state upon ligand engagement (5) and
induces the expression ofa gamut ofgenes,
including CYPlAI, genes of fatty acid
metabolism, cytokines, and/or growth and
differentiation factors (6). The binding
affinity ofAhR to TCDD and thus suscep-
tibility varies between different animal
species and also interindividually in out-
bred populations. Neither the overall toxi-
city of TCDD to humans nor TCDD-
induced effects on the human immune sys-
tem is known.
We examined 11 workers with defined
TCDD body burdens who had been inad-
vertently exposed to TCDD for several
years. We evaluated possible deviations in
peripheral blood lymphocyte subsets using
multi-parameter immunofluorescence of
relevant markers (7) and examined in vitro
effects of TCDD on immunocompetence
ofT- and B-cells.
Materials and Methods
Eleven workers, 45-63 years ofage, partici-
pated in this study. Theyhad been exposed
to high doses of TCDD and other poly-
chlorinated dibenzo-p-dioxins between
1966 and 1976 during production and
maintenance operations at a chemical facto-
ry producing 2,4,5-trichlorophenol. Six
other exposed workers declined to partici-
pate. The level of TCDD in blood lipids
was determined in 1989 and 1992 by the
ERGO-Forschungsgesellschaft, Hamburg,
Germany, or Bioscientia, Moers, Germany,
respectively, according to standard mass
spectrometry (8). Ten age-matched, healthy,
males with no known TCDD exposure his-
tory, working in the same company in office
jobs, volunteered as controls. Informed con-
sent was obtained from all subjects.
Peripheral blood (50 ml) was drawn by
venipuncture into a sterile tube, containing
100 U of heparin/ml blood. Peripheral
blood mononuclear cells (PBMC) were iso-
lated by Ficoll-Hypaque (Pharmacia Fine
Chemicals, Uppsala, Sweden) density cen-
trifugation.
For single or dual fluorescence analysis,
aliquots of 1 x 106 peripheral blood lym-
phocytes were spun down and incubated
for 10 min at 6-8°C with fluoresceinated
antibodies as recommended by the manu-
facturer. Cells were washed two times after
staining, and data from 10,000 cells were
collected immediately in list-mode on a
FACScan flow cytometer, using appropriate
compensation settings (Becton-Dickinson,
Mountain View, California). Forward and
rectangular light scatter gates were used.
The following fluorochromed antibodies
were used: mouse anti-CD3FITC (clone
SK7), mouse anti-CD4FITC (clone SK3),
mouse anti-CD8PE/CD8FITC (clone SKI),
mouse anti-CD19FITC (done 4G7), all from
Becton-Dickinson; mouse anti-CD45ROPE
(clone UCH-LI) and anti-CD45RAPE
(clone F8-11-3), both from Serotec (Oxford,
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UK); mouse anti-CD56PE (clone B 159.5;
Pharmingen, San Diego, California); and
anti-CD57 (Leu7; Becton-Dickinson).
We cultured 5 x 104 cells/well in 96-
well round-bottom plates containing 150
j,l RPMI 1640 culture medium, supple-
mented with 5% heat-inactivated pooled
human ABO serum, L-glutamine (2 mM),
sodium pyruvate (1 mM), nonessential
amino acids, 50 U/ml penicillin, and 50
U/ml streptomycin.
Cells were cultured in triplicate either
with medium alone or in the presence of9
pg/ml PHA (Sigma, St. Louis, Missouri) or
6 pg/ml pokeweed mitogen (PWM; Sigma)
for 3 days at 37°C in a water-saturated 5%
CO2 atmosphere. On day4 ofculture, cells
were pulsed with 1 pCi of 3H-thymidine
and then harvested 20 hr later to determine
incorporated radioactivity (f3 counter LS
6000 IC, Beckman Instruments, Munchen,
Germany).
The human lymphocyte antigen (HLA)
phenotype of peripheral blood mononu-
clear cells was determined by standard
microlymphotoxicity assays using A,B,C
plates (One-lambda, Canoga Park,
California) and HLA-class II plates (Biotest,
Dreieich, Germany). For mixed lymphocyte
cultures, washed cells were resuspended in
serum-free CG-medium (Vitronex,
Vilshofen, Switzerland), supplemented with
60 pig/ml gentamcycin. We seeded 5 x 104
responder cells in triplicate into 96-well
round-bottom microtiter plates. For "one-
way" mixed lymphocyte cultures, the same
number of irradiated (30 Gy) stimulator
cells were added. Stimulator cells were from
a pool of cells from 20 allogeneic, HLA-
unrelated individuals. For "third-party"
suppressor assays, the lymphocytes from
dioxin-exposed or control persons were irra-
diated (30 Gy) and added to the pooled
allogeneic cells (in this case unirradiated).
Interleukin-2 (IL-2)-inducible prolifer-
ation ofT-cells was measured after adding
30 U/ml recombinant IL-2 per 5 x 10I
cells. Recombinant IL-2 was a gift of P.
Loeliger (Sandoz, Switzerland).
Results
The concentration ofTCDD in the blood
of 11 workers exposed between 2 and 11
years before 1976 (with one exception, see
Table 1) was determined in 1989 or 1992,
i.e., 13-15 years after the last exposure.
Table 1 summarizes the exposure parame-
ters and the health status of the TCDD-
exposed workers determined at a thorough
general medical examination in 1992. The
TCDD values in blood fat differed up to
20-fold between individuals, yet even the
lowest burdens were well above the average
level of the German population, which is
about 4 pg/g blood fat (9). At the time of
the study, five persons still suffered from
chloracne, ofwhich one had chronic gastri-
tis and one hyperthyreosis. Two subjects
displayed a disturbance offatty acid metab-
olism. The others appeared healthy.
The frequencies ofvarious lymphocyte
subsets were determined by flow cytometry.
The percentages of B-cells (CD19), T-cells
(CD3), and subsets thereof were deter-
mined, e.g., T-helper cells (CD4), cytotoxic
T-cells (CD8), virgin helper/inducer T-cells
(CD4CD45RA) as well as primed
helper/inducer (CD4CD45RO). Moreover,
natural killer cells (CD56 and CD57) and
HLA-DR expression were measured. Some
of the subset markers were previously
shown to be sensitive parameters of
TCDD-exposure in marmosets, a new
world primate species (7). Table 2 shows
the result ofthe analysis for each ofthe 11
TCDD-exposed individuals and for the
controls. No difference between controls
and the mean values ofthe TCDD-exposed
group was evident for any of the lympho-
cytes subsets analyzed. Note that the per-
Table 1.TCDD exposure length, severity, and health status8
Subject Years of TCDD in Year of
no. Smoker exposure blood fat(pg/g) exam Chloracne Clinical manifestations
1 Yes 1966-76 874 1989 Yes Chronic gastritis
2 No 1966-76 274 1992 Yesb Hyperthyreosis
3 No 1973-76 264 1989 No None
4 Yes 1971-74 190 1989 No Disturbance in fatty acid metabolism
S Yes 1974-76 54 1992 No Disturbance in fatty acid metabolism
6 No 1981-82 90 1989 No None
7 No 1971-76 43 1992 No High incidence ofcolds
8 Yes/Noc 1963-76 720 1992 Yes None
9 No 1972-76 95 1989 No None
10 No 1967-74 287 1989 Yesd None
11 No 1973-75 734 1992 Yes None
aThe concentration of 2,3,7,8-TCDD in the blood fat of 11 workers who had been exposed for different
intervals between 1966 and 1981 to 2,3,7,8-TCDD and related congeners was determined, and a general
medical examination was done in 1989 or 1992, atthe sametime.
bChloracne from 1974to 1981.
CPastsmoker.
dChloracne for a short period in 1974.
Table2. Lymphocyte subsets in peripheral blood mononuclear cells of 11 industrial workers and controls
Subject no. Controls(n=10)
Parameter 1 2 3 4 5 6 7 8 9 10 11 Mean ± SD Mean ± SD
Age (years)8 58 63 57 58 46 45 56 61 46 49 50 53.5 54.4
2,3,7,8-TCDD 874 274 264 190 54 90 43 720 95 287 734 329.5 ND
level (pg/g blood fat)
Lymphocyte subsetsb
CD3 76.9 68.8 76.1 71.7 66.7 55 76.7 63.8 64.5 81.0 74.4 70.5 ± 7.6 70.9 ± 10.5
CD4 50 51 61 47 47 41 43 49 44 52 38 47.6± 8.1 48.5± 10.6
CD8 25 17 21 27 24 20 30 15 21 27 34 23.7 ± 5.6 22.1±3.9
CD19 10.3 5.9 5.7 6.2 5.2 12.2 8.6 13.1 7.2 6.1 2.0 7.3± 3.2 6.8± 3.4
CD56 3 5 5 5 6 9 5 4 9 4 5 5.4± 1.9 5.5± 1.6
CD57 12 15 19 20 11 15 30 10 21 17 35 19.4±8.3 20.0±7.5
CD4CD45RO 12 18 12 7 11 10 15 22 14 5 11 12.4±4.8 11.0±4.5
CD4 CD45RA 18 13 18 16 20 14 13 6 ND 15.7 7 16.2 ± 5.5 12.0 ± 6.0
CD3 HLA-DR 3 0 2 5 4 4 4 3 5 7 19 5.1 ± 4.9 4.5± 2.5
ND, notdetermined.
aLymphocyte subsets were determined in cells ofTCDD-exposed persons versus unexposed, age-matched controls. The age given refers tothe age atthetime of
TCDD determination (see Table 1).
bValues are percentage oftotal, ficollated peripheral blood mononuclear cells.
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centage of CD56-expressing cells (i.e., nat-
ural killer cells) is comparatively lower than
reported in the literature for younger indi-
viduals, possibly aphenomenon ofage (24).
Peripheral blood lymphocytes were test-
ed for their capacity to respond to mitogens
PHAand PWM. As shown in Figure 1, lym-
phocytes from TCDD-exposed and control
persons responded equally well to mitogen
stimulation, with some individual variation.
There was no statistically significant differ-
ence between the response ofthe two groups
(p = 0.5641). Moreover, when we corrected
the data for the interindividual differences in
T-cell frequencies in the blood (see Table 2),
it becomes even more clear that TCDD
exposure does not affect the mitogen-
induced proliferative capacity (p = 0.7823;
data for PHA stimulation not shown). No
correlation existed between individual
TCDD levels in the blood nor the age ofthe
persons and the respective proliferative
capacityoftheirlymphocytes (notshown)..
We tested the capacity of T-cells
("responder cells") from dioxin-exposed
persons to specifically react against irradiat-
ed, HLA-different, allogeneic lymphocytes
("stimulator cells") in a mixed-lymphocyte
culture. In another experiment, we added
irradiated responder cells as a third party to
a pool of unirradiated peripheral blood
mononuclear cells from 20 different
donors. Whereas the former assay measures
the response to allo-major histocompatibii-
ty complex, the latter is used to detect sup-
pressive factors/cells in the responder cell
population, which would inhibit the respec-
tive response of the unirradiated cells (10).
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As shown in Figure 2, the responder cells of
the TCDD-exposed persons proliferated
less in response to irradiated stimulator cells
(p<0.05 by Student's t-test). Moreover, the
third-party mixed lymphocyte reaction
against unirradiated stimulator cells
revealed a small amount of suppressive
activity in the responder cells of dioxin-
exposed individuals, resulting in a decreased
overall proliferation of T-cells (Fig. 2,).
This significant suppression (p <0.01 by
Student's t-test) is indicative of a reduced
T-helper cell response (11). However, the
actual number ofT-helper cells was unaf-
fected byTCDD (seeTable 2).
The capacity ofa pool ofT-cells to pro-
liferate upon IL-2 stimulation is a parame-
ter ofnormal T-cell function and correlates
with the presence ofpreactivated T-cells in
the pool, which would result in a higher
overall proliferative response. Peripheral
blood mononuclear cells of TCDD-
exposed individuals and control persons
were co-cultured with a low dose of IL-2
for 4 days. The cells of TCDD-exposed
persons revealed a reduced capacity to pro-
liferate with IL-2 (Fig. 2; p<0.05). The val-
ues for one exposed individual were not
included in the data due to an excessively
high proliferation rate. Those particular
values reflected an extreme preactivation of
the T-cells, which is typical for the begin-
ning ofan acute, but undetected, infection.
No atopic status is known for that person.
However, it must be noted that the statisti-
cally significant differences between the
TCDD-exposed and control persons disap-
pear ifthis one value is included.
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Figure 1. Proliferation capacity of(A) peripheral blood T-cells in the presence of phytohemagglutinin and
(B) T-cells and B-cells in the presence of pokeweed mitogen in individuals exposed to dioxins about 20
years ago.We cultured 1 x105 Ficoll-isolated peripheral blood mononuclear cells in the presence of mito-
gen for 4 days, and pulsed with 3H-thymidine 20 hr before harvesting. Shown are the means and SDs
(bars) oftriplicate cultures (TCDD exposed and controls). The order of symbols for dioxin-exposed per-
sons are arranged from 1 to 7 and 9 to 11 asthey appear in Tables 1 and 2;the value for person 8 was not
determined.
Discussion
Ever since the major accident at Seveso,
Italy, the danger ofdioxin has been recog-
nized. The acute toxicity dose ofTCDD is
among the lowest for any known chemical
substance. Fortunately, no people died at
Seveso, and most scientists believe humans
to be at the lower end of the susceptibility
scale. However, TCDD continues to be
inadvertently released into the environ-
ment, and little is known on the long-term
effects oflow doses. In Germany, the body
burden ofthe general population is about 4
ppt TCDD in blood fat, with an estimated
daily uptake, mostly by food, of26 pg (9).
The immune system seems to be the
most sensitive target of TCDD action in
experimental animals. Humoral as well as
cellular components of immune responses
are suppressed by TCDD (2,12,13). The
interaction of the human immune system
with TCDD has remained controversial.
Studies with an evolutionarily closely related
species, the primate Callithrixjacchus (mar-
mosets), revealed sensitive parameters for
TCDD-induced alterations in peripheral
blood lymphocyte subsets. Using combina-
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Figure 2. Proliferation of peripheral blood
mononuclear cells (PBMCs) of dioxin-exposed
persons and controls. Tested were 1) the sponta-
neous response, 2) the response toward irradiat-
ed stimulator PBMCs of unrelated HLA-haplotypes
(MLR), 3) the third-party response of irradiated
PBMCs of TCDD-exposed persons toward the
mixed-lymphocyte reaction ofthe pool of unirradi-
ated stimulator cells (MLR*), and 4) the prolifera-
tive capacity in response to interleukin-2 stimula-
tion (IL-2). Cultures were done in triplicate. Each
dot represents the mean of the count per minute
values of the PBMCs of one person. For p-values
from Student's t-test, see text. One dioxin-
exposed person (value in parentheses) displayed
a very high response in all assays, probably indi-
cating preactivated T-cells (e.g., due to an unde-
tected, ongoing infection). This value was disre-
garded for statistical calculations (seetext).
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tions ofsurface markers, changes in the fre-
quency of memory (CD4+, CDw29+), sup-
pressor-inducer (CD4+, CD45RA+) T-cells
and B-cells (CD20+) were found (7). In vitro
studies on human blood leukocytes after
accidental or occupational exposure to
TCDD were ambiguous with respect to the
immunological alterations induced (14).
Some authors reported suppressed responses
(15), whereas others reported enhanced
mitogen-induced lymphoproliferative
responses (16) and increased percentages in
suppressor/cytotoxic T-cells and the absolute
number ofnatural killer cells in the peripher-
al blood (17,18). Others found no effect on
mitogen stimulation (19) and no deviations
in peripheral blood subsets (20,21). With the
exception of one of these studies (21), the
actual body burden had not been deter-
mined. It is interesting to note that also in
experimental animals the immunosuppres-
sive effects ofTCDD are commonly detect-
ed byfunctional tests (i.e., following antigen-
specific stimulation), rather than unspecifi-
cally, by mitogen stimulation, for example.
Thus, it was important to choose an appro-
priately sensitive test system.
We tested possible immunosuppression
in TCDD-exposed workers using three
parameters oflymphocyte competence. We
found no difference compared to the age-
matched control persons for the distribution
of lymphocyte subsets in the blood. This
result is in accordance with the more elabo-
rate study ofNeubert and co-workers (7), in
which they applied the experience gained in
Callithrixjacchus on TCDD-sensitive lym-
phocyte subsets to humans, but failed to
detect any decrease in leukocyte subsets
associated with elevated dioxin body bur-
dens. In the present study, we demonstrated
a small but significant difference in the allo-
response ofT-cells and in their proliferative
response to IL-2. Moreover, the lympho-
cytes ofTCDD-exposed persons displayed a
suppressive activity, which inhibited an
ongoing allo-response of HLA-unrelated
lymphocytes. This is probably due to an
increased proliferation response of T-cells
counteracting the CD4+ T-helper-1 cells,
representing the primary responder type in
mixedlymphocyte cultures.
As reported previously (22), the
changes in immunocompetence we
observed in vitro did not correlate with
obvious diseases related to severe immun-
odeficiency such as certain cancers and
infections. The workers were generally
healthy and, with one exception, had no
history of increased susceptibility to infec-
tions. The functional reserve of the
immune system is enormous, so that
impaired immune responsiveness need not
have pathological consequences (23).
Indeed, the term "immunotoxic" has not
been properly defined (24). Only a large,
well-controlled epidemiological study
might reveal the actual health effects of
subtle changes in immunocompetence.
The reduced immunocompetence in
vitro observed here fails to correlate with a
reduced number of lymphocyte subsets.
Thus, TCDD-induced immunosuppres-
sion is more likely mediated by a reduced
functionality ofindividual cells rather than
by a reduction in cell numbers circulating
in the blood.
Thymus involution, a reduction of thy-
mus weight and cellularity, is a hallmark of
TCDD exposure. In mice, TCDD skews
the distribution of lymphocyte subsets
(25,26). However, although a link between
thymus events and peripheral immunosup-
presssion is often implicidy assumed, noth-
ing is known about the balance between
thymocyte/T-cell generation and migration
to the periphery under TCDD treatment.
The thymus normally begins to atrophy at
about the time of sexual maturity in mice
and humans (27). T-cell numbers and other
leukocytes in the periphery remain unaffect-
ed in TCDD-exposed versus nonexposed
persons (28), thus an additional atrophic
effect on the thymus by TCDD might not
be detectable in people exposed to TCDD
as adults over about 30 years ofage.
We found no correlation between
TCDD levels in blood and performance of
peripheral blood mononuclear cells in the
assays. This is not surprising, since the
development ofchloracne, the major effect
ofdioxin exposure on humans, in individ-
uals affected by the Seveso accident did not
correlate to the severityofTCDD exposure.
It is now generally accepted that the Ah
receptor mediates dioxin toxicity, and the
reason for variability in individual responses
is likely due to genetic differences in Ah
receptor alleles in different individuals.
We have presented here data where the
actual body burden ofthe individuals ana-
lyzed were kiown. We know of only two
other such studies. In accordance with our
data, no phenotypic difference between
lymphocyte subsets in the exposed and
unexposed groups was found, with the
exception ofCD8 cells, which were slightly
increased (21,22). However, the present
study is the first to demonstrate reduced
immunocompetence of lymphocytes from
TCDD-exposed humans.
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condition the response ofxenobiotics.There will be particular emphasis on compounds present in
diet. In addition to the opportunity for poster and oral presentations,the following subjects will be
covered in scientific sessions:
* mechanisms oftoxicity * inhibitory and inducing effects
* role of biotransformation enzymes * natural and artificial food toxins
Local Organizing Committee For further information please contact:
Angel Messenguer, CID, CSIC, Barcelona (Chairman) Prof Angel Messeguer
Josefina Casas, CID, CSIC, Barcelona Department ofBiological Organk Chemistry, CID (CSIC)
Maria-Jose Gomez-Lechon, Hospital "La Fe" Valencia J. Girona, 19. 08034 Barcelona, Spain
Margarita G. Ladona, IMIM Barcelona Telephone: (34) -3-4006121
Antonio Martinez-Tobed, Lab. Almirrall Barcelona FAX: (34)-3-2045904 E-mail: issx96@cid.csices
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